bendamustine hydrochloride has been researched along with Exanthem in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kashiwagi, M; Kawai, R; Kawashiri, T; Shimizu, T; Uchida, M; Uesawa, Y | 1 |
| Bolis, SAM; Civettini, I | 1 |
| Al-Rohil, RN; Kheterpal, MK; Leckey, BD; Selim, MA | 1 |
| Ganesan, P; Malipatil, B; Sagar, TG; Sundersingh, S | 1 |
| Gavini, A; Olszewski, AJ; Telang, GH | 1 |
5 other study(ies) available for bendamustine hydrochloride and Exanthem
| Article | Year |
|---|---|
Time to Onset of Bendamustine-associated Skin Damage Using the Spontaneous Reporting System.
Topics: Adverse Drug Reaction Reporting Systems; Bendamustine Hydrochloride; Drug-Related Side Effects and Adverse Reactions; Exanthema; Herpes Zoster; Humans; Quality of Life | 2022 |
Bullous pemphigoid-like rash induced by bendamustine.
Topics: Bendamustine Hydrochloride; Exanthema; Humans; Pemphigoid, Bullous; Skin | 2023 |
Cutaneous involvement by T-cell prolymphocytic leukemia presenting as livedoid vasculopathy.
Topics: Aged; Alemtuzumab; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bendamustine Hydrochloride; Biopsy; Diagnosis, Differential; Disease Progression; Exanthema; Extremities; Fatal Outcome; Humans; Hyperpigmentation; Immunohistochemistry; Leukemia, Prolymphocytic, T-Cell; Male; Skin Neoplasms; Torso; Vascular Diseases | 2021 |
Preliminary experience with the use of bendamustine: a peculiar skin rash as the commonest side effect.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Drug Therapy, Combination; Exanthema; Female; Humans; India; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Nitrogen Mustard Compounds; Prednisolone; Retrospective Studies; Rituximab; Vincristine | 2011 |
Generalized purpuric drug exanthem with hemorrhagic plaques following bendamustine chemotherapy in a patient with B-prolymphocytic leukemia.
Topics: Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Biopsy; Drug Eruptions; Exanthema; Female; Humans; Leukemia, Prolymphocytic, B-Cell; Nitrogen Mustard Compounds; Purpura; Skin; Treatment Outcome | 2012 |